Research outputs

  1. 2019
  2. Enhanced dermatologic toxicity following concurrent treatment with palbociclib and radiation therapy: A case report

    Messer, J. A., Ekinci, E., Patel, T. A. & Teh, B. S., May 1 2019, In : Reports of Practical Oncology and Radiotherapy. 24, 3, p. 276-280 5 p.

    Research output: Contribution to journalArticle

  3. 2018
  4. A Behavior-Modification, Clinical-Grade Mobile Application to Improve Breast Cancer Survivors' Accountability and Health Outcomes

    Stubbins, R., He, T., Yu, X., Puppala, M., Ezeana, C. F., Chen, S., Valdivia y Alvarado, M., Ensor, J., Rodriguez, A., Niravath, P., Chang, J., Wong, S. T. C. & Patel, T., Nov 1 2018, In : JCO Clinical Cancer Informatics. 2, p. 1-11 11 p.

    Research output: Contribution to journalArticle

  5. 2017
  6. Deep learning analytics for diagnostic support of breast cancer disease management

    He, T., Puppala, M., Ogunti, R., Mancuso, J. J., Yu, X., Chen, S., Chang, J. C., Patel, T. A. & Wong, S. T. C., Apr 11 2017, 2017 IEEE EMBS International Conference on Biomedical and Health Informatics, BHI 2017. Institute of Electrical and Electronics Engineers Inc., p. 365-368 4 p. 7897281

    Research output: Chapter in Book/Report/Conference proceedingConference contribution

  7. 2016
  8. Correlating mammographic and pathologic findings in clinical decision support using natural language processing and data mining methods

    Patel, T. A., Puppala, M., Ogunti, R. O., Ensor, Jr., J. E., He, T., Shewale, J. B., Ankerst, D. P., Kaklamani, V. G., Rodriguez, A. A., Wong, S. T. C. & Chang, J. C., Aug 29 2016, In : Cancer.

    Research output: Contribution to journalArticle

  9. Cell-free DNA as a molecular tool for monitoring disease progression and response to therapy in breast cancer patients

    Liang, D. H., Ensor, Jr., J. E., Liu, Z. B., Patel, A., Patel, T., Chang, J. C. & Rodriguez, A. A., Jan 1 2016, In : Breast Cancer Research and Treatment. 155, 1, p. 139-149 11 p.

    Research output: Contribution to journalArticle

  10. 2015
  11. Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer

    Granados-Principal, S., Liu, Y., Guevara, M. L., Blanco, E., Choi, D. S., Qian, W., Patel, T., Rodriguez, A. A., Cusimano, J., Weiss, H. L., Zhao, H., Landis, M. D., Dave, B., Gross, S. S. & Chang, J. C., Feb 22 2015, In : Breast Cancer Research. 17, 1, 25.

    Research output: Contribution to journalArticle

  12. 2014
  13. Erratum: Dual HER2 blockade: Preclinical and clinical data

    Patel, T., Dave, B., Rodriguez, A. A., Chang, J. C., Perez, E. A. & Colon-Otero, G., Nov 6 2014, (Accepted/In press) In : Breast Cancer Research.

    Research output: Contribution to journalArticle

  14. Dual HER2 blockade: Preclinical and clinical data

    Patel, T., Dave, B., Rodriguez, A. A., Chang, J. C., Perez, E. A. & Colon-Otero, G., Aug 1 2014, In : Breast Cancer Research. 16, 4, 419.

    Research output: Contribution to journalArticle

  15. 2013
  16. RC0639: Phase II study of paclitaxel, trastuzumab, and lapatinib as adjuvant therapy for early stage HER2-positive breast cancer

    Moreno-Aspitia, A., Dueck, A. C., Ghanem-Cañete, I., Patel, T., Dakhil, S., Johnson, D., Franco, S., Kahanic, S., Colon-Otero, G., Tenner, K. S., Rodeheffer, R., McCullough, A. E., Jenkins, R. B., Palmieri, F. M., Northfelt, D. & Perez, E. A., Apr 1 2013, In : Breast Cancer Research and Treatment. 138, 2, p. 427-435 9 p.

    Research output: Contribution to journalArticle

  17. 2010
  18. Metastatic breast cancer

    Patel, T. & Perez, E. A., Dec 1 2010, Management of Breast Diseases. Springer Berlin Heidelberg, p. 425-449 25 p.

    Research output: Chapter in Book/Report/Conference proceedingChapter

  19. Erratum: Changes to adjuvant systemic therapy in breast cancer: A decade in review (Clinical Breast Cancer (2010) 10:3 (196-208) DOI: 10.3816/CBC.2010.n. 027)

    Saurel, C. A., Patel, T. & Perez, E. A., Oct 1 2010, In : Clinical Breast Cancer. 10, 5

    Research output: Contribution to journalArticle

  20. Changes to adjuvant systemic therapy in breast cancer: A decade in review

    Saurel, C. A., Patel, T. & Perez, E. A., Jun 1 2010, In : Clinical Breast Cancer. 10, 3, p. 196-208 13 p.

    Research output: Contribution to journalArticle

  21. Efficacy of ixabepilone in ER/PR/HER2-negative (triple-negative) breast cancer

    Perez, E. A., Patel, T. & Moreno-Aspitia, A., Jun 1 2010, In : Breast Cancer Research and Treatment. 121, 2, p. 261-271 11 p.

    Research output: Contribution to journalArticle

  22. Breast cancer in latinas: Gene expression, differential response to treatments, and differential toxicities in latinas compared with other population groups

    Patel, T. A., Colon-Otero, G., Hume, C. B., Copland, J. A. & Perez, E. A., May 28 2010, In : Oncologist. 15, 5, p. 466-475 10 p.

    Research output: Contribution to journalArticle

  23. 2009
  24. North Central Cancer Treatment Group (NCCTG) N0432: Phase II trial of docetaxel with capecitabine and bevacizumab as first-line chemotherapy for patients with metastatic breast cancer

    Perez, E. A., Hillman, D. W., Dentchev, T., Le-Lindqwister, N. A., Geeraerts, L. H., Fitch, T. R., Liu, H., Graham, D. L., Kahanic, S. P., Gross, H. M., Patel, T., Palmieri, F. M. & Dueck, A. C., Nov 9 2009, In : Annals of Oncology. 21, 2, p. 269-274 6 p., mdp512.

    Research output: Contribution to journalArticle

ID: 2283258